Dr. Swee Lay Thein and Dr. Stuart Orkin won the $3 million Breakthrough Prize in Life Sciences for their work toward a ...

Researchers have developed a modified CRISPR gene-editing tool with potential to silence the extra chromosome causing Down ...

National Institutes of Health (NIH) released the following: A National Institutes of Health (NIH)-funded research team has ...

Boston scientists honored at the Breakthrough Prize for gene editing, muons, Pantheon+ and new symmetry theory.

Qatar has taken a landmark step in precision medicine after Sidra Medicine became the first hospital in the country — and one ...

In December 2023, the U.S. Food and Drug Administration (FDA) approved ‘Casgevy,’ a treatment utilizing CRISPR gene-editing ...

Scientists have taken an important step toward a gene therapy that could one day turn off the extra genetic material that ...

Rice (Oryza sativa L.) feeds over half of the global population and is central to food security across Asia, Africa, and the Americas. To meet the world’s growing demand, breeders are pursuing ideal ...

(Nanowerk News) In a major step forward for cancer care, researchers at ChristianaCare’s Gene Editing Institute have shown that disabling the NRF2 gene with CRISPR technology can reverse chemotherapy ...

Torie Bosch is the First Opinion editor at STAT. Celena Lozano’s son Benny, who turned 5 in November, loves trains, trucks — anything that goes. He also has a rare disease, PURA syndrome. Earlier this ...

Vertex Pharmaceuticals' (NASDAQ: VRTX) stock price is up, but its Casgevy sales partner, CRISPR Therapeutics (NASDAQ: CRSP), is the real buy for long-term investors. Shares of Vertex, a biotech based ...